Crypto for Entrepreneurs: Building a Business in the Blockchain Era
Blockchain technology has given a new meaning to entrepreneurship and changed the traditional business model of running a business in innovative ways. Don’t mistake blockchain for another trendy term; it’s a way to increase transparency and scalability and to become a global influence. For those entrepreneurs who look ahead, blockchain and cryptocurrency represent possibilities that […]
Patterson Belknap Announces IP Litigator Kathryn Bi as Its Partner
Patterson Belknap announced that Kathryn Bi has joined the firm as a Partner in its Litigation department and as a member of the Patent Litigation practice. Ms. Bi helps clients resolve their toughest intellectual property and commercial cases, focusing her practice on complex technology disputes. She has successfully represented tech companies in numerous high-stakes patent cases. Ms. […]
PureTech Announces the Appointment of Michele Holcomb, PhD, to the Board of Directors
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, recently announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb’s appointment will take effect as of September 23, 2024. She brings more […]
Botanical Solution Inc. Announces Closing of Series A Funding
Botanical Solution Inc. (BSI) announced it has closed another $7.6 million financing, as part of Series A, that will fund the commencement of in-house production of QS-21, pharmaceutical grade vaccine adjuvant. Using cost-effective and scalable proprietary methods, BSI will expand QS-21 use in broader vaccine applications. Mr. Salinas made the announcement at Harvard University’s Global […]
Swisslog Healthcare appoints Brian Roberts as SVP of Medication Management, North America
Swisslog Healthcare, a global industry leader in pharmacy and transport automation solutions, announced the appointment of Brian Roberts as the Senior Vice President of Sales and Services in North America for the Medication Management business unit. With a wealth of experience in pharmacy automation, business-to-business healthcare applications, and executive leadership, Roberts brings a proven track record of success to […]
Prothena appoints Daniel G. Welch as Director and Chair Designate
Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced yesterday the appointment of Daniel G. Welch to its Board of Directors as an independent director and Chair Designate following a comprehensive search process in connection with the board’s regular succession planning. Upon election […]
Gilead Sciences announces the acquisition of CymaBay Therapeutics
Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. announced yesterday a definitive agreement under which Gilead will acquire CymaBay for $32.50 per share in cash or a total equity value of $4.3 billion. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver […]
Lysando adds Dr. Holger Zimmermann to its advisory board
Lysando, a leading innovator in the fight against antibiotic-resistant bacteria, announced the appointment of Dr. Holger Zimmermann to its Advisory Board. Dr. Zimmermann’s distinguished career in the pharmaceutical sector and healthcare industry brings a wealth of experience, positioning him as a key asset in Lysando’s mission to eliminate the fear of harmful bacteria worldwide. Currently […]
Buzzreach and Oncoshot announce collaboration
Buzzreach and Oncoshot, two prominent entities in the clinical trials domain, have announced an impactful collaboration to accelerate clinical trials in Japan. The former specializes in clinical trial site recruitment and retention and project management solutions, while the latter operates a cutting-edge real-time health insights exchange platform. The collaboration will extend to Oncoshot’s strategic contract research […]
Vial appoints Emma C. Moran as the new VP of Central Nervous Systems
Vial, a global tech-driven CRO providing next-generation clinical trial management services, announced the addition of Emma C. Moran to their team. Moran will be the CRO’s new VP of Central Nervous Systems (CNS), bringing with her an impressive 28-year track record in the clinical research industry. Moran’s expertise spans various domains within the pharmaceutical sector, having worked with both […]
